{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:59:36Z","timestamp":1786121976574,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH139660"],"award-info":[{"award-number":["RS-2023-KH139660"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2023-KH139660"],"award-info":[{"award-number":["RS-2023-KH139660"]}],"id":[{"id":"https:\/\/ror.org\/00fdzyk40","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-24533285"],"award-info":[{"award-number":["RS-2025-24533285"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2025-24533285"],"award-info":[{"award-number":["RS-2025-24533285"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Ovarian cancer treatment remains challenging due to aggressive metastasis and the complex tumor microenvironment (TME). Solanum nigrum L. (SN), a berry-bearing plant rich in bioactive phytochemicals, offers promising multi-target anticancer potential. This study elucidated the systemic molecular mechanisms of SN fractions against ovarian cancer by integrating network pharmacology, molecular docking, and in vitro models. In silico analyses and molecular docking identified apoptosis, metastasis-related pathways, and NF-\u03baB (RELA) as core targets. For in vitro validation, butanol (SNBT) and methylene chloride (SNMC) fractions of SN were evaluated in SKOV3 cells. SNBT significantly induced caspase-3-dependent apoptosis, while SNMC effectively suppressed cancer cell migration and invasion without cytotoxicity. Furthermore, both fractions markedly downregulated phosphorylated AKT and NF-\u03baB, experimentally confirming the suppression of the AKT\/NF-\u03baB signaling axis. Crucially, in a tumor-associated macrophage co-culture model, SNMC attenuated the pro-metastatic TME by reducing MMP2, MMP9, and VEGF secretion. Conclusively, SN exerts potent anticancer effects through distinct fractional activities, such as driving apoptosis and blocking metastasis, mediated via AKT\/NF-\u03baB inhibition and TME remodeling. These findings highlight SN-derived fractions as promising multi-target therapeutic candidates against ovarian cancer.<\/jats:p>","DOI":"10.3390\/ijms27167076","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:01:36Z","timestamp":1786089696000},"page":"7076","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling\u00a0the Dual Mechanisms of Solanum nigrum L. Fractions Against Ovarian Cancer via AKT\/NF-\u03baB and Tumor Microenvironment Modulation: An In Silico\u00a0and In Vitro Study"],"prefix":"10.3390","volume":"27","author":[{"given":"Eun-Ji","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Food science and Biotechnology, Woosuk University, Wanju 55338, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9192-5879","authenticated-orcid":false,"given":"Eun-Hye","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Korean Pharmacy, Woosuk University, Wanju 55338, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi-Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Korean Pharmacy, Woosuk University, Wanju 55338, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Deok","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Korean Pharmacy, Woosuk University, Wanju 55338, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-6814","authenticated-orcid":false,"given":"Jung-Hye","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-5648","authenticated-orcid":false,"given":"Ji-Hye","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Korean Pharmacy, Woosuk University, Wanju 55338, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Biernacka, K., Lukasiewicz, H., Samulak, D., Piekarska, E., Romanowicz, H., and Makowska, M. (2025). Ovarian Cancer-Epidemiology, Classification, Pathogenesis, Treatment, and Estrogen Receptors\u2019 Molecular Backgrounds. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104611"},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12967-025-06508-0","article-title":"Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jones, A.P., Zhao, Y., Rueda, B.R., Yeku, O.O., and Xu, L. (2026). Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27020939"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41420-021-00554-5","article-title":"Platinum drugs and taxanes: Can we overcome resistance?","volume":"7","author":"Sazonova","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1038\/s41401-022-00983-7","article-title":"Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"158065","DOI":"10.1016\/j.phymed.2026.158065","article-title":"Plant-derived natural compounds targeting drug resistance in ovarian cancer: Molecular mechanisms and therapeutic perspectives","volume":"155","author":"Ao","year":"2026","journal-title":"Phytomedicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional Chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/qjmed\/hcaf103","article-title":"Integrating multi-omics technologies with traditional Chinese medicine to enhance cancer research and treatment","volume":"118","author":"Wen","year":"2025","journal-title":"QJM"},{"key":"ref_11","first-page":"78","article-title":"Solanum nigrum: Current perspectives on therapeutic properties","volume":"16","author":"Jain","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chen, X., Dai, X., Liu, Y., Yang, Y., Yuan, L., He, X., and Gong, G. (2022). Solanum nigrum Linn.: An Insight into Current Research on Traditional Uses, Phytochemistry, and Pharmacology. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.918071"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Campisi, A., Acquaviva, R., Raciti, G., Duro, A., Rizzo, M., and Santagati, N.A. (2019). Antioxidant Activities of Solanum nigrum L. Leaf Extracts Determined in in vitro Cellular Models. Foods, 8.","DOI":"10.3390\/foods8020063"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, H., Lv, J.L., Zheng, Q.S., and Li, J. (2023). Active components of Solanum nigrum and their antitumor effects: A literature review. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1329957"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1534735415588826","article-title":"Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells","volume":"14","author":"Wang","year":"2015","journal-title":"Integr. Cancer Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/jssc.201801165","article-title":"Preparative isolation and purification of steroidal glycoalkaloid from the ripe berries of Solanum nigrum L. by preparative HPLC-MS and UHPLC-TOF-MS\/MS and its anti-non-small cell lung tumors effects in vitro and in vivo","volume":"42","author":"Shi","year":"2019","journal-title":"J. Sep. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1021\/jf062406m","article-title":"Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells","volume":"55","author":"Lin","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ling, B., Xiao, S., Yang, J., Wei, Y., Sakharkar, M.K., and Yang, J. (2019). Probing the Antitumor Mechanism of Solanum nigrum L. Aqueous Extract against Human Breast Cancer MCF7 Cells. Bioengineering, 6.","DOI":"10.3390\/bioengineering6040112"},{"key":"ref_19","first-page":"5965","article-title":"Phytocompounds and modulatory effects of Anacardium microcarpum (cajui) on antibiotic drugs used in clinical infections","volume":"9","author":"Waczuk","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8178294","DOI":"10.1155\/2019\/8178294","article-title":"Evaluation of the use of different solvents for phytochemical constituents, antioxidants, and in vitro anti-inflammatory activities of Severinia buxifolia","volume":"2019","author":"Truong","year":"2019","journal-title":"J. Food Qual."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/s12967-025-06643-8","article-title":"Unraveling the role of M2 TAMs in ovarian cancer dynamics: A systematic review","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_22","first-page":"561","article-title":"Ovarian Cancer: An Overview","volume":"91","author":"Penny","year":"2020","journal-title":"Radiol. Technol."},{"key":"ref_23","first-page":"363","article-title":"Targeted therapy in ovarian cancer","volume":"12","author":"Lim","year":"2016","journal-title":"Womens Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.gco.0000192996.20040.24","article-title":"Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients","volume":"18","author":"Kayl","year":"2006","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100995","DOI":"10.1016\/j.phyplu.2026.100995","article-title":"Synergistic phytochemicals in multi-target drug discovery for complex diseases: A narrative review","volume":"6","author":"Nnaemeka","year":"2026","journal-title":"Phytomed. Plus"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zon, A., and Bednarek, I. (2023). Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087585"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Delbrouck, J.A., Desgagne, M., Comeau, C., Bouarab, K., Malouin, F., and Boudreault, P.L. (2023). The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review. Molecules, 28.","DOI":"10.3390\/molecules28134957"},{"key":"ref_29","first-page":"1545","article-title":"Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway","volume":"54","author":"Fu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13046-015-0272-0","article-title":"Inactivation of PI3-K\/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells","volume":"34","author":"Chen","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.tiv.2015.03.012","article-title":"Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity","volume":"29","author":"Sani","year":"2015","journal-title":"Toxicol. Vitr."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Brauneck, F., Oliveira-Ferrer, L., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Schulze Zur Wiesch, J., Ding, Y., Qi, M., and Hell, L. (2023). Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1250258"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevOncog.2024053830","article-title":"Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy","volume":"29","author":"Bui","year":"2024","journal-title":"Crit. Rev. Oncog."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"86608","DOI":"10.18632\/oncotarget.13474","article-title":"M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor\/matrix metalloproteinase 9 intercellular feedback loop","volume":"7","author":"Carroll","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xu, C., Chen, J., Tan, M., and Tan, Q. (2025). The role of macrophage polarization in ovarian cancer: From molecular mechanism to therapeutic potentials. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1543096"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ma, Q., Kang, R., Xu, R., Guan, Y., Chang, S., and Li, S. (2025). Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1614815"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7076\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:05:54Z","timestamp":1786089954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":36,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167076"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167076","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}